Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Juniper Pharmaceuticals Inc (NASDAQ:JNP)

5.24
Delayed Data
As of 11:06am ET
 +0.036 / +0.69%
Today’s Change
3.65
Today|||52-Week Range
6.10
-6.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues20.9M11.2M14.0M13.0M
 
 
 
 
 
Cost of Goods Sold5.3M6.1M7.1M7.1M
 
 
 
 
 
Depreciation And Amortization464.0K484.0K591.0K593.0K
 
 
 
 
 
 
Operating ExpensesGross Income15.2M4.7M6.3M5.3M
 
 
 
 
 
General Expenses6.0M6.1M6.7M6.0M
 
 
 
 
 
Research And Development1.4M1.3M1.6M2.3M
 
 
 
 
 
Total Operating Expenses11.8M12.7M14.3M13.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.1M-1.5M-356.0K-779.0K
 
 
 
 
 
Extraordinary Charge0.000.000.00-756.0K
 
 
Interest Expense On Debt23.0K28.0K30.0K47.0K
 
 
 
 
 
Other Expenses564.0K42.0K10.0K127.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.7M-1.4M-376.0K-1.5M
 
 
 
 
 
Income Taxes-44.0K0.000.00-45.0K
 
 
 
Preferred Dividend-7.0K-7.0K-452.0K0.00
 
 
 
 
Net Income9.6M-1.4M-376.0K-1.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.8M10.8M10.8M10.8M
 
 
 
 
 
Shares To Calculate EPS Diluted10.9M10.8M11.0M10.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.88-$0.13-$0.03-$0.13
 
 
 
 
 
EPS Diluted$0.88-$0.13-$0.03-$0.13